This was unexpected as CD44 has been extensively studied for roles in tumorigenesis (Morath et al., 2016), metastasis (Orian-Rousseau, 2010), and chemo-resistance (Wang et al., 2014; Xu et al., 2015), in solid tumors as well as hematological malignancies (Thapa and Wilson, 2016). The gene discussed is CD44; the disease is hematologic disorder.